President Biden, citing the need for maximum flexibility in the nation’s vaccination program, today announced a deal for the U.S. government to purchase an additional 100 million doses of Johnson & Johnson’s single-shot COVID-19 vaccine.

Johnson & Johnson is working with Merck to increase supply, making such a deal possible.

The purchase doubles the nation’s projected supply of Johnson & Johnson doses, to 200 million. The intent of the purchase is to prepare for long-term supply needs, including the eventual vaccination of children and the possible need for booster shots to protect against COVID-19 variants.

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…